Disclosed are compounds that are agonists or antagonists of the S1P5 receptor, compositions comprising said compounds, and methods of using said compounds and compositions. In certain embodiments, said compounds are 1-benzylazetidine-3-carboxylic acid derivatives. In certain embodiments, said methods relate to the treatment of neuropatic pain and/or a neurodegenerative disorder. In certain embodiments, said compounds may be used in combination with a second therapeutic agent.
本文披露了作为S1P5受体激动剂或拮抗剂的化合物,包括含有这些化合物的组合物,以及使用这些化合物和组合物的方法。在某些实施例中,这些化合物是1-苄基氮杂环丙
氨酸衍
生物。在某些实施例中,这些方法涉及治疗神经痛和/或神经退行性疾病。在某些实施例中,这些化合物可以与第二治疗剂结合使用。